BREXOGEN Inc.
PrivateLast Round
Series C
Sep 1, 2023
Total Funding Raised
$25.82M
Company Overview
BREXOGEN Inc. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series C round in September 2023.
BREXOGEN Inc. is a biotechnology company that develops cell-free regenerative medicines using its proprietary stem cell-derived exosome platform technology to target incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BREXOGEN Inc. Comparables
Compare BREXOGEN Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExoStemTech | 87% | |
| ILIAS Biologics Inc. | 87% | |
| EXORPHIA Inc. | 84% |
For institutional investors. Book with your work email.
BREXOGEN Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 1, 2023 | ||||
| Series B | Dec 1, 2021 | ||||
| Series A | Sep 21, 2020 | ||||
| Pre Seed | Oct 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BREXOGEN Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTC Investment | Series B, Series C, Series A |
| Korea Investment Partners | Series B, Series C, Series A |
| Timefolio Asset Management | Series B, Series C, Pre Seed, Series A |
| Stonebridge Ventures | Series A |
| KB Securities | Series B, Series A |
| Korea Development Bank | Series B, Series C |
| Korea Venture Investment Corporation | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2023
$9M round with participation from Timefolio Asset Management and UTC Investment.
- Oct 1, 2019
$2.1M round from Tigris Investment and Timefolio Asset Management.
For institutional investors. Book with your work email.
BREXOGEN Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BREXOGEN Inc.'s valuation, stock price, and market status.
Is BREXOGEN Inc. a public or private company?
BREXOGEN Inc. is a private company.
What is the current stock price of BREXOGEN Inc.?
BREXOGEN Inc. is a private company, so its shares have no public market price. Caplight tracks BREXOGEN Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BREXOGEN Inc. worth (valuation)?
Valuation information for BREXOGEN Inc. is not publicly available.
Can I buy BREXOGEN Inc. stock?
BREXOGEN Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BREXOGEN Inc.'s last funding round?
BREXOGEN Inc.'s most recent funding round was Series C on September 1, 2023.
Who are the main investors in BREXOGEN Inc.?
Key investors in BREXOGEN Inc. include Korea Investment Partners, Korea Investment Partners.
Will BREXOGEN Inc. IPO soon?
No public IPO plans have been announced for BREXOGEN Inc..
How can I track BREXOGEN Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BREXOGEN Inc.'s shares on secondary markets.